Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have been awarded three multi-year grants totaling $6 million ...

(Reuters) -The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo Nordisk, special vouchers that will speed up the review of their ...

Breast and ovarian cancers remain major health threats for women, often detected late due to subtle symptoms. Know about the ...

After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique technology.

The reason behind the phenomenon is the sharpened tooth, which develops ulcers inside the mouth, displaced tooth, the area ...

On National Cancer Awareness Day 2025, learn how adopting healthy habits and preventive care can significantly lower your risk of cancer and promote long-term wellbeing.

Mouth cancer cases in England have hit a record high – with HPV infections identified as a leading cause in the rise among ...

NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) announced that clinical data on rusfertide in polycythemia vera, including the ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced positive initial results from a Phase 1a/1b clinical trial of STK-012 in first-line, PD-L1 negative nonsquamous (NSQ) ...

Cancer remains one of the country’s most serious public health concerns. According to the National Cancer Registry Programme, India records nearly 800,000 new cases every year, with tobacco-related ...

Actor Dipika Kakar has opened up about her cancer diagnosis, revealing that the disease was confined to the tumour and that she is currently undergoing targeted therapy. Sharing her experience, the ...

Dr. Simon Plyte, Biomunex's CSO, has been invited to present MAIT engagers preclinical data during an oral communication at 2025 SITC Annual meeting With a very attractive safety and efficacy ...